"Indinavir" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent and specific HIV protease inhibitor that appears to have good oral bioavailability.
| Descriptor ID |
D019469
|
| MeSH Number(s) |
D03.383.725.385
|
| Concept/Terms |
L-735 524- L-735 524
- L 735 524
- L735 524
- L-735,524
- L 735,524
- L735,524
|
Below are MeSH descriptors whose meaning is more general than "Indinavir".
Below are MeSH descriptors whose meaning is more specific than "Indinavir".
This graph shows the total number of publications written about "Indinavir" by people in this website by year, and whether "Indinavir" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2002 | 0 | 1 | 1 |
| 2003 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Indinavir" by people in Profiles.
-
Hammer SM, Bassett R, Squires KE, Fischl MA, Demeter LM, Currier JS, Mellors JW, Morse GD, Eron JJ, Santana JL, DeGruttola V. A randomized trial of nelfinavir and abacavir in combination with efavirenz and adefovir dipivoxil in HIV-1-infected persons with virological failure receiving indinavir. Antivir Ther. 2003 Dec; 8(6):507-18.
-
Sension MG, Bellos NC, Johnson J, Sepulveda GE, DeJesus E, Santana JL, Ames MH, Goodwin SD. Lamivudine 300 mg QD versus continued lamivudine 150 mg BID with stavudine and a protease inhibitor in suppressed patients. HIV Clin Trials. 2002 Sep-Oct; 3(5):361-70.